These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 39232232)
1. Gender-affirming therapy reshapes the immune systems of trans men. Sidik S Nature; 2024 Sep; 633(8029):264-265. PubMed ID: 39232232 [No Abstract] [Full Text] [Related]
2. Transgender men: clinical care and implications in reproductive medicine: introduction. de Ziegler D; de Sutter P Fertil Steril; 2021 Oct; 116(4):919-921. PubMed ID: 34399947 [TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence. Defreyne J; Vantomme B; Van Caenegem E; Wierckx K; De Blok CJM; Klaver M; Nota NM; Van Dijk D; Wiepjes CM; Den Heijer M; T'Sjoen G Andrology; 2018 May; 6(3):446-454. PubMed ID: 29602229 [TBL] [Abstract][Full Text] [Related]
5. Impact of Exogenous Testosterone on Reproduction in Transgender Men. Moravek MB; Kinnear HM; George J; Batchelor J; Shikanov A; Padmanabhan V; Randolph JF Endocrinology; 2020 Mar; 161(3):. PubMed ID: 32105330 [TBL] [Abstract][Full Text] [Related]
6. Immune system adaptation during gender-affirming testosterone treatment. Lakshmikanth T; Consiglio C; Sardh F; Forlin R; Wang J; Tan Z; Barcenilla H; Rodriguez L; Sugrue J; Noori P; Ivanchenko M; Piñero Páez L; Gonzalez L; Habimana Mugabo C; Johnsson A; Ryberg H; Hallgren Å; Pou C; Chen Y; Mikeš J; James A; Dahlqvist P; Wahlberg J; Hagelin A; Holmberg M; Degerblad M; Isaksson M; Duffy D; Kämpe O; Landegren N; Brodin P Nature; 2024 Sep; 633(8028):155-164. PubMed ID: 39232147 [TBL] [Abstract][Full Text] [Related]
7. Endometrial findings among transgender and gender nonbinary people using testosterone at the time of gender-affirming hysterectomy. Hawkins M; Deutsch MB; Obedin-Maliver J; Stark B; Grubman J; Jacoby A; Jacoby VL Fertil Steril; 2021 May; 115(5):1312-1317. PubMed ID: 33583596 [TBL] [Abstract][Full Text] [Related]
8. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men. Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638 [TBL] [Abstract][Full Text] [Related]
9. Short- and long-term clinical skin effects of testosterone treatment in trans men. Wierckx K; Van de Peer F; Verhaeghe E; Dedecker D; Van Caenegem E; Toye K; Kaufman JM; T'Sjoen G J Sex Med; 2014 Jan; 11(1):222-9. PubMed ID: 24344810 [TBL] [Abstract][Full Text] [Related]
10. Systematic Review on Gender-Affirming Testosterone Therapy and the Risk of Breast Cancer: A Challenge for Physicians Treating Patients from Transgender and Gender-Diverse Populations. Pamulapati S; Conroy M; Cortina C; Harding E; Kamaraju S Arch Sex Behav; 2024 May; 53(5):1969-1980. PubMed ID: 38148450 [TBL] [Abstract][Full Text] [Related]
12. Implications for management of ovarian cancer in a transgender man: Impact of androgens and androgen receptor status. Aubrey C; Saad N; Köbel M; Mattatall F; Nelson G; Glaze S Gynecol Oncol; 2021 May; 161(2):342-346. PubMed ID: 33663874 [TBL] [Abstract][Full Text] [Related]
13. Gender-affirming hormones and surgery in transgender children and adolescents. Mahfouda S; Moore JK; Siafarikas A; Hewitt T; Ganti U; Lin A; Zepf FD Lancet Diabetes Endocrinol; 2019 Jun; 7(6):484-498. PubMed ID: 30528161 [TBL] [Abstract][Full Text] [Related]
14. New-Onset Abdominopelvic Pain After Initiation of Testosterone Therapy Among Trans-Masculine Persons: A Community-Based Exploratory Survey. Grimstad FW; Boskey E; Grey M LGBT Health; 2020 Jul; 7(5):248-253. PubMed ID: 32552294 [No Abstract] [Full Text] [Related]
15. Testosterone and Breast Cancer in Transmen: Case Reports, Review of the Literature, and Clinical Observation. Tanini S; Fisher AD; Meattini I; Bianchi S; Ristori J; Maggi M; Lo Russo G Clin Breast Cancer; 2019 Apr; 19(2):e271-e275. PubMed ID: 30655171 [No Abstract] [Full Text] [Related]
16. Contraception across the transmasculine spectrum. Krempasky C; Harris M; Abern L; Grimstad F Am J Obstet Gynecol; 2020 Feb; 222(2):134-143. PubMed ID: 31394072 [TBL] [Abstract][Full Text] [Related]
17. Endocrinological and ovarian histological investigations in assigned female at birth transgender people undergoing testosterone therapy. Borrás A; Manau MD; Fabregues F; Casals G; Saco A; Halperin I; Mora M; Goday A; Barral Y; Carmona F Reprod Biomed Online; 2021 Aug; 43(2):289-297. PubMed ID: 34244072 [TBL] [Abstract][Full Text] [Related]
18. Laboratory Changes During Gender-Affirming Hormone Therapy in Transgender Adolescents. Millington K; Lee JY; Olson-Kennedy J; Garofalo R; Rosenthal SM; Chan YM Pediatrics; 2024 May; 153(5):. PubMed ID: 38567424 [TBL] [Abstract][Full Text] [Related]
19. The uterus in transgender men. Carbonnel M; Karpel L; Cordier B; Pirtea P; Ayoubi JM Fertil Steril; 2021 Oct; 116(4):931-935. PubMed ID: 34364678 [TBL] [Abstract][Full Text] [Related]
20. Effects of gender affirming hormone treatment in transgender individuals - a retrospective cohort study. Muir CA; Guttman-Jones M; Man EJ Endocrine; 2024 Jul; 85(1):370-379. PubMed ID: 38386168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]